Edition:
United States

Veloxis Pharmaceuticals A/S (VELOX.CO)

VELOX.CO on Copenhagen Stock Exchange

1.19DKK
10:59am EST
Change (% chg)

kr.0.01 (+0.85%)
Prev Close
kr.1.18
Open
kr.1.19
Day's High
kr.1.19
Day's Low
kr.1.17
Volume
797,543
Avg. Vol
1,293,723
52-wk High
kr.2.03
52-wk Low
kr.0.93

VELOX.CO

Chart for VELOX.CO

About

Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, is a Denmark-based company active in the biotechnology and pharmaceutical industry. It is primarily focused on the development of its transplant immunosuppression product candidate, LCP-Tacro. LCP-Tacro is being developed as a once-daily dosage version of tacrolimus for... (more)

Overall

Beta: 0.20
Market Cap(Mil.): kr.1,988.47
Shares Outstanding(Mil.): 1,703.37
Dividend: --
Yield (%): --

Financials

  VELOX.CO Industry Sector
P/E (TTM): -- 45.86 30.46
EPS (TTM): -0.14 -- --
ROI: -208.61 -1.27 14.82
ROE: -373.74 -1.00 16.24

BRIEF-Veloxis Q3 net loss narrows to $7.6 million

* Q3 net revenue $2.2 million versus $1.8 million in Q2 and $0.5 million year ago

Nov 16 2016

BRIEF-Veloxis Pharmaceuticals Q2 operating loss widens to $9.6 million

* Said on Wednesdays Q2 revenue $1.8 million versus $783,000 year ago

Aug 25 2016

Earnings vs. Estimates